Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Indaptus Therapeutics, Inc. (INDP)

Indaptus completes private placement, to issue 20,338,974 shares to purchasers

Neutral Impact 3 of 5 financing Written later

Indaptus Therapeutics said it completed a private placement on October 16, 2026, after receiving the full purchase price from each purchaser under the purchase agreement, as amended. The company will issue an aggregate of 20,338,974 shares to the purchasers, which adds to the number of shares outstanding. The filing does not state the total proceeds or price per share.

Key points

  • Private placement closed on October 16, 2026, with full purchase price received from each purchaser.
  • Company will issue an aggregate of 20,338,974 shares to the purchasers.
  • The filing does not disclose the total proceeds or the price per share.

The filing

CompanyIndaptus Therapeutics, Inc. (INDP)
Form8-K, current report
Filed with the SECOct 20, 2026, 4:38 PM ET
Accession number0001493152-26-047770

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.